Skip to main content

Many Indicators of Anger Expression Decrease With Age in Women

Medically reviewed by Carmen Pope, BPharm. Last updated on July 10, 2025.

via HealthDay

THURSDAY, July 10, 2025 -- Aging is significantly related to anger in women, with most indicators of anger expression decreasing with age, according to a study published online July 1 in Menopause.

Nancy Fugate Woods, Ph.D., from the University of Washington in Seattle, and colleagues examined the influence of aging and reproductive aging stages on women's reports of anger among 501 participants aged 35 to 55 years from the Seattle Midlife Women's Health Study population-based cohort. Participants completed the State-Trait Anger Inventory (STAXI; (State Anger, Trait Anger, Anger Temperament, Anger Reaction, Anger-in, and Anger Control subscales) and the Symptom Checklist 90 (SCL-90) Hostility scale on up to five occasions during the study.

The researchers found a significant relation for age with most anger measures, with increases in State and Trait Anger and Anger Control with age. Significant decreases were seen in Anger Temperament, Anger Reaction, Anger Expressed Aggressively, and Hostility with age. There was no relation for Anger Suppressed with age. When accounting for the effects of age, Reproductive Aging Stages significantly affected State and Trait Anger and Anger Temperament; after the late reproductive stages, each decreased with women's progression through further reproductive aging stages.

"Educating women about the possibility of mood changes during these vulnerable windows and actively managing symptoms can have a profound effect on overall quality of life and health," Monica Christmas, M.D., associate medical director for The Menopause Society, said in a statement.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Elinzanetant Safe, Effective for Moderate-to-Severe Vasomotor Symptoms

TUESDAY, Sept. 30, 2025 -- Elinzanetant, a dual neurokinin-targeted therapy, is effective for treating menopause-associated moderate-to-severe vasomotor symptoms (VMS), according...

Drop in Hospital Salaries, Staffing Reported After Private Equity Acquisitions

FRIDAY, Sept. 26, 2025 -- U.S. hospitals that undergo private equity acquisition may reduce salaries and staffing after acquisition, especially in emergency departments (EDs) and...

Poor Mental Health Outcomes More Likely With Hyperemesis Gravidarum

FRIDAY, Sept. 26, 2025 -- Hyperemesis gravidarum is associated with an increased risk for poorer mental health outcomes compared with pregnancy without hyperemesis gravidarum...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.